MOCKSVILLE, N.C., April 23, 2026 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company focused on nicotine reduction and plant biotechnology, today announced corporate updates regarding a new testing services agreement with North Carolina State University aimed at validating tobacco varieties featuring improved leaf quality and increased crop yields with the same low-nicotine content. The initiative builds upon 22nd Century’s proprietary reduced nicotine content technology platform, which utilizes advanced plant breeding and biotechnology to reduce nicotine content in tobacco to minimally addictive levels. The Company’s reduced nicotine tobacco is the foundation of its FDA-authorized VLN® combustible cigarette products and represents years of scientific development in plant genetics and regulatory...

Solution empowers small business owners to maintain a consistent, accurate presence as AI reshapes digital search results CHICAGO, April 23, 2026 (GLOBE NEWSWIRE) — With Small Business Month approaching in May, TransUnion (NYSE: TRU) today announced the launch of Digital Business Profile, an affordable, easy-to-use solution designed to help small businesses ensure their information is represented accurately across the digital search ecosystem. Accurate business information directly influences customer behavior: Google research found that customers are 70% more likely to visit and 50% more likely to consider purchasing from businesses with a complete Business Profile on Google. Digital Business Profile allows small business owners to manage essential details, including business name and location, contact information, hours of operation,...

MALVERN, Pa., April 23, 2026 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-founder of Ocugen will present at Oppenheimer’s 3rd Annual Innovation on the Island Biotech Summit from April 27-29, 2026 in Rio Grande, Puerto Rico; and Abhi Gupta, MBA, Executive Vice President, Commercial and Business Development at Ocugen will present at the 2026 Cell & Gene Meeting on the Mediterranean being held April 28-30, 2026 in Rome, Italy. “I look forward to sharing our story with new audiences and building enthusiasm for why now is the time to get to know Ocugen,” said Dr. Musunuri. “Our gene-agnostic approach to addressing all mutations related to major...

CARLSBAD, Calif., April 23, 2026 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced it will file its financial results with SEDAR for fiscal year 2025 ended December 31, 2025, on Wednesday, April 29, 2026, after market hours. The company will issue a press release reviewing its financial results for the fourth quarter and fiscal year on the morning of April 30, 2026 before market trading. Later that morning, management will host a conference call for investors at 11:00 am ET/8:00am PT to discuss the results. Fourth Quarter and Fiscal Year 2025 Conference Call Details Date and Time: Thursday, April 30, 2026, at 11:00 a.m. ET / 8:00 a.m. PT Call-in Information: Interested parties...

Company Advances Nationwide Commercial Rollout as Demand for Automation Surges Across U.S. Facilities Sector SINGAPORE, April 23, 2026 (GLOBE NEWSWIRE) — Primech Holdings Limited (Nasdaq: PMEC) (“Primech” or the “Company”), through its autonomous robotics subsidiary Primech AI Pte. Ltd., today announced the acceleration of its U.S. expansion strategy, supported by its selection for the SelectUSA Tech program and participation in the 2026 SelectUSA Investment Summit (May 3–6, 2026, National Harbor, Maryland) following an invitation from the U.S. Embassy in Singapore. This acceleration positions Primech to capitalize on intensifying enterprise demand for AI-powered facility automation and supports the Company’s long-term growth strategy through institutional-scale commercial deployment in the world’s largest facilities services market. The...

SCOTTSDALE, Ariz., April 23, 2026 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), the nation’s largest franchisor of chiropractic care through The Joint Chiropractic® network, announced it will report its 2026 first quarter financial results on Thursday, May 7, 2026, after the market close and host a conference call and simultaneous webcast at 5:00 p.m. ET that day. During the call, The Joint Corp. President and CEO Sanjiv Razdan and CFO Scott Bowman will review the Company’s financial results and provide a business update, followed by a question-and-answer session. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing (833) 630-0823 or (412) 317-1831 and asking to be joined into the ‘The Joint’ call approximately 15 minutes prior to the start time. The live webcast of...